Effects of Provastatin, a 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, on Glucose Tolerance in Patients With Essential Hypertension

Baba, Tsuneharu; Kodama, Tatsuhiko; Yajima, Yoshitada; Ishizaki, Takashi

doi:10.2337/diacare.16.1.402b

Article navigation

Letters| January 01 1993

Effects of Provastatin, a 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, on Glucose Tolerance in Patients With Essential Hypertension

Tsuneharu Baba, MD;

Tsuneharu Baba, MD

Division of Clinical Pharmacology, Clinical Research Institute, National Medical Center

Tokyo

Third Department of Internal Medicine, Hirosaki University School Of Medicine

Hirosaki

Department of Internal Medicine, Kitazato University School of Medicine

Sagamihara, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Tatsuhiko Kodama, MD;

Tatsuhiko Kodama, MD

Division of Clinical Pharmacology, Clinical Research Institute, National Medical Center

Tokyo

Third Department of Internal Medicine, Hirosaki University School Of Medicine

Hirosaki

Department of Internal Medicine, Kitazato University School of Medicine

Sagamihara, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Yoshitada Yajima, MD;

Yoshitada Yajima, MD

Division of Clinical Pharmacology, Clinical Research Institute, National Medical Center

Tokyo

Third Department of Internal Medicine, Hirosaki University School Of Medicine

Hirosaki

Department of Internal Medicine, Kitazato University School of Medicine

Sagamihara, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Takashi Ishizaki, MD

Division of Clinical Pharmacology, Clinical Research Institute, National Medical Center

Tokyo

Third Department of Internal Medicine, Hirosaki University School Of Medicine

Hirosaki

Department of Internal Medicine, Kitazato University School of Medicine

Sagamihara, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Takashi Ishizaki, Md, Director, Clinical Research Institute,National Medical Center, Toyama 1-21-2, Shinjuku-Ku, Tokyo 162, Japan

Diabetes Care 1993;16(1):402–404

https://doi.org/10.2337/diacare.16.1.402b

PubMed:

8422826

Effects of Provastatin, a 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, on Glucose Tolerance in Patients With Essential Hypertension

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Effects of Provastatin, a 3-hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor, on Glucose Tolerance in Patients With Essential Hypertension

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only